Galectin-1 in injured rat spinal cord: Implications for macrophage phagocytosis and neural repair

Molecular and Cellular Neuroscience

Volumn 64, Issue , 2015, Pages 84-94

  Gaudet, Andrew D ^a,b   Sweet, David R ^a,b,c   Polinski, Nicole K ^a,b,d   Guan, Zhen ^a,b   Popovich, Phillip G ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Extracellular matrix; Glial scar; Inflammation; Neuroinflammation; Phagocytosis; Spinal cord injury

Indexed keywords

ED1 PROTEIN; GALECTIN 1; LIPID; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PHAGOCYTOSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXPERIMENTAL SPINAL CORD CONTUSION; EXPERIMENTAL SPINAL CORD INJURY; FEMALE; LIPOPHAGOCYTOSIS; MACROPHAGE; NERVE FIBER REGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SPATIOTEMPORAL ANALYSIS; SPINAL CORD REGENERATION; TISSUE REPAIR; UPREGULATION; ANIMAL; GENETICS; METABOLISM; PHAGOCYTOSIS; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ASTROCYTES; FEMALE; GALECTIN 1; MACROPHAGES; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; SPINAL CORD REGENERATION; UP-REGULATION;

EID: 84920125516     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.12.006     Document Type: Article

References (53)

1. Akazawa C., Nakamura Y., Sango K., Horie H., Kohsaka S. Distribution of the galectin-1 mRNA in the rat nervous system: its transient upregulation in rat facial motor neurons after facial nerve axotomy. Neuroscience 2004, 125:171-178.
2. Barrionuevo P., Beigier-Bompadre M., Ilarregui J.M., Toscano M.A., Bianco G.A., Isturiz M.A., Rabinovich G.A. A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J. Immunol. 2007, 178:436-445.
3. Camby I., Le M.M., Lefranc F., Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006, 16:137R-157R.
4. Carrico K.M., Vaishnav R., Hall E.D. Temporal and spatial dynamics of peroxynitrite-induced oxidative damage after spinal cord contusion injury. J. Neurotrauma 2009, 26:1369-1378.
5. Correa S.G., Sotomayor C.E., Aoki M.P., Maldonado C.A., Rabinovich G.A. Opposite effects of galectin-1 on alternative metabolic pathways of l-arginine in resident, inflammatory, and activated macrophages. Glycobiology 2003, 13:119-128.
6. Damoiseaux J.G., Dopp E.A., Calame W., Chao D., MacPherson G.G., Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994, 83:140-147.
7. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 2008, 209:378-388.
8. Echigo Y., Sugiki H., Koizumi Y., Hikitsuchi S., Inoue H. Activation of RAW264.7 macrophages by oxidized galectin-1. Immunol. Lett. 2010, 131:19-23.
9. Fukaya K., Hasegawa M., Mashitani T., Kadoya T., Horie H., Hayashi Y., Fujisawa H., Tachibana O., Kida S., Yamashita J. Oxidized galectin-1 stimulates the migration of Schwann cells from both proximal and distal stumps of transected nerves and promotes axonal regeneration after peripheral nerve injury. J. Neuropathol. Exp. Neurol. 2003, 62:162-172.
10. Gaudet A.D., Steeves J.D., Tetzlaff W., Ramer M.S. Expression and functions of galectin-1 in sensory and motoneurons. Curr. Drug Targets 2005, 6:419-425.
11. Gaudet A.D., Leung M., Poirier F., Kadoya T., Horie H., Ramer M.S. A role for galectin-1 in the immune response to peripheral nerve injury. Exp. Neurol. 2009, 220:320-327.
12. Gaudet A.D., Popovich P.G., Ramer M.S. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J. Neuroinflammation 2011, 8:110.
13. Greenhalgh A.D., David S. Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J. Neurosci. 2014, 34:6316-6322.
14. Han H., Xia Y., Wang S., Zhao B., Sun Z., Yuan L. Synergistic effects of galectin-1 and reactive astrocytes on functional recovery after contusive spinal cord injury. Arch. Orthop. Trauma Surg. 2011, 131:829-839.
15. Herbert D.R., Holscher C., Mohrs M., Arendse B., Schwegmann A., Radwanska M., Leeto M., Kirsch R., Hall P., Mossmann H., Claussen B., Forster I., Brombacher F. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004, 20:623-635.
16. Holness C.L., Simmons D.L. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993, 81:1607-1613.
17. Horie H., Kadoya T., Hikawa N., Sango K., Inoue H., Takeshita K., Asawa R., Hiroi T., Sato M., Yoshioka T., Ishikawa Y. Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. J. Neurosci. 2004, 24:1873-1880.
18. Inagaki Y., Sohma Y., Horie H., Nozawa R., Kadoya T. Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur. J. Biochem. 2000, 267:2955-2964.
19. Ishibashi S., Kuroiwa T., Sakaguchi M., Sun L., Kadoya T., Okano H., Mizusawa H. Galectin-1 regulates neurogenesis in the subventricular zone and promotes functional recovery after stroke. Exp. Neurol. 2007, 207:302-313.
20. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoskar A.R., Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102:37-50.
21. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
22. Kurihara D., Ueno M., Tanaka T., Yamashita T. Expression of galectin-1 in immune cells and glial cells after spinal cord injury. Neurosci. Res. 2010, 66:265-270.
23. Lee S., Huen S., Nishio H., Nishio S., Lee H.K., Choi B.S., Ruhrberg C., Cantley L.G. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 2011, 22:317-326.
24. Lekishvili T., Hesketh S., Brazier M.W., Brown D.R. Mouse galectin-1 inhibits the toxicity of glutamate by modifying NR1 NMDA receptor expression. Eur. J. Neurosci. 2006, 24:3017-3025.
25. Liu D., Shan Y., Valluru L., Bao F. Mn (III) tetrakis (4-benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: comparison with methylprednisolone. BMC Neurosci. 2013, 14:23.
26. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009, 27:451-483.
27. Martini R., Fischer S., Lopez-Vales R., David S. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008, 56:1566-1577.
28. McGraw J., McPhail L.T., Oschipok L.W., Horie H., Poirier F., Steeves J.D., Ramer M.S., Tetzlaff W. Galectin-1 in regenerating motoneurons. Eur. J. Neurosci. 2004, 20:2872-2880.
29. McGraw J., Oschipok L.W., Liu J., Hiebert G.W., Mak C.F., Horie H., Kadoya T., Steeves J.D., Ramer M.S., Tetzlaff W. Galectin-1 expression correlates with the regenerative potential of rubrospinal and spinal motoneurons. Neuroscience 2004, 128:713-719.
30. McGraw J., Gaudet A.D., Oschipok L.W., Kadoya T., Horie H., Steeves J.D., Tetzlaff W., Ramer M.S. Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons. Exp. Neurol. 2005, 195:103-114.
31. McPhail L.T., Stirling D.P., Tetzlaff W., Kwiecien J.M., Ramer M.S. The contribution of activated phagocytes and myelin degeneration to axonal retraction/dieback following spinal cord injury. Eur. J. Neurosci. 2004, 20:1984-1994.
32. Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., van W.P., Wagers A.J., Williams A., Franklin R.J., Ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013, 16:1211-1218.
33. Moiseeva E.P., Williams B., Samani N.J. Galectin 1 inhibits incorporation of vitronectin and chondroitin sulfate B into the extracellular matrix of human vascular smooth muscle cells. Biochim. Biophys. Acta 2003, 1619:125-132.
34. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
35. Outenreath J.L., Jones A.L. Influence of an endogenous lectin substrate on cultured dorsal root ganglion cells. J. Neurocytol. 1992, 21:788-795.
36. Pesce J.T., Ramalingam T.R., Mentink-Kane M.M., Wilson M.S., El Kasmi K.C., Smith A.M., Thompson R.W., Cheever A.W., Murray P.J., Wynn T.A. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009, 5:e1000371.
37. Plachta N., Annaheim C., Bissière S., Lin S., Rüegg M., Hoving S., Müller D., Poirier F., Bibel M., Barde Y.A. Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells. Nat. Neurosci. 2007, 10:712-719.
38. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 1997, 377:443-464.
39. Pruss H., Kopp M.A., Brommer B., Gatzemeier N., Laginha I., Dirnagl U., Schwab J.M. Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau. Brain Pathol. 2011, 21:652-660.
40. Qu W.S., Wang Y.H., Wang J.P., Tang Y.X., Zhang Q., Tian D.S., Yu Z.Y., Xie M.J., Wang W. Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochem. Res. 2010, 35:1716-1724.
41. Qu W.S., Wang Y.H., Ma J.F., Tian D.S., Zhang Q., Pan D.J., Yu Z.Y., Xie M.J., Wang J.P., Wang W. Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia. J. Neurochem. 2011, 116:217-226.
42. Quinta H.R., Pasquini J.M., Rabinovich G.A., Pasquini L.A. Glycan-dependent binding of galectin-1 to neuropilin-1 promotes axonal regeneration after spinal cord injury. Cell Death Differ. 2014, 21:941-955.
43. Rabinovich G.A., Sotomayor C.E., Riera C.M., Bianco I., Correa S.G. Evidence of a role for galectin-1 in acute inflammation. Eur. J. Immunol. 2000, 30:1331-1339.
44. Rabinovich G.A., Liu F.T., Hirashima M., Anderson A. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand. J. Immunol. 2007, 66:143-158.
45. Sakaguchi M., Shingo T., Shimazaki T., Okano H.J., Shiwa M., Ishibashi S., Oguro H., Ninomiya M., Kadoya T., Horie H., Shibuya A., Mizusawa H., Poirier F., Nakauchi H., Sawamoto K., Okano H. A carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7112-7117.
46. Sasaki T., Hirabayashi J., Manya H., Kasai K., Endo T. Galectin-1 induces astrocyte differentiation, which leads to production of brain-derived neurotrophic factor. Glycobiology 2004, 14:357-363.
47. Stancic M., van H.J., Thijssen V.L., Gabius H.J., van D.V., Hoekstra D., Baron W. Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 2011, 37:654-671.
48. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 2004, 24:2182-2190.
49. Tamatani T., Kotani M., Miyasaka M. Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Eur. J. Immunol. 1991, 21:627-633.
50. Thomas A.C., Sala-Newby G.B., Ismail Y., Johnson J.L., Pasterkamp G., Newby A.C. Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production. Arterioscler. Thromb. Vasc. Biol. 2007, 27:571-577.
51. Vallieres N., Berard J.L., David S., Lacroix S. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 2006, 53:103-113.
52. Yamane J., Nakamura M., Iwanami A., Sakaguchi M., Katoh H., Yamada M., Momoshima S., Miyao S., Ishii K., Tamaoki N., Nomura T., Okano H.J., Kanemura Y., Toyama Y., Okano H. Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets. J. Neurosci. Res. 2010, 88:1394-1405.
53. Yin P., Knolhoff A.M., Rosenberg H.J., Millet L.J., Gillette M.U., Sweedler J.V. Peptidomic analyses of mouse astrocytic cell lines and rat primary cultured astrocytes. J. Proteome Res. 2012, 11:3965-3973.